1887

n SA Pharmaceutical Journal - Shingles vaccine in preventing shingles and postherpetic neuralgia - focus on

Volume 86 Number 6
  • ISSN : 2221-5875
  • E-ISSN: 2220-1017

Abstract

Infection with the varicella-zoster virus (VZV) causes two distinct clinical manifestations, namely varicella (chickenpox) and herpes zoster (shingles). Primary infection, which generally occurs during childhood, results in varicella (chickenpox). Following the initial infection, the virus enters the nerves and travels along the nerves to infect dorsal route ganglia (nerve cells), where it remains dormant/latent for many years. In the latent state the virus is inactive and may never cause symptoms again or the virus may be reactivated in the future (usually many years after the initial infection). Reactivation of the latent VZV results in shingles. VZV-specific host cell-mediated immune responses are essential for maintaining latency and limiting the likelihood for reactivation.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/journal/10520/EJC-1a7052f273
2019-12-31
2020-09-20

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error